Related Experiment Video
Updated: Jan 16, 2026

04:46
Glioblastoma Relapse Post-Resection Model for Therapeutic Hydrogel Investigations
Published on: February 24, 2023
2.2K
Optical Microscopy Predictions of Focal Recurrence in Glioblastoma
Medrxiv : the Preprint Server for Health Sciences
|October 3, 2025
Summary
Artificial intelligence (AI) models can predict glioblastoma (GBM) recurrence by analyzing tumor infiltration in surgical samples. This AI-driven approach identifies high-risk areas, potentially improving targeted therapies for recurrent brain tumors.
Area of Science:
- Neuro-oncology
- Artificial Intelligence in Medicine
- Computational Pathology
Background:
- Glioblastoma (GBM) frequently recurs after initial treatment, posing a significant clinical challenge.
- Current management of recurrent GBM lacks a standard of care.
- Predicting recurrence location is crucial for optimizing advanced-stage therapies.
Purpose of the Study:
- To develop and validate an AI-based model for predicting the risk of focal glioblastoma recurrence.
- To assess the utility of AI-estimated tumor infiltration in predicting recurrence at resection margins.
Main Methods:
- An AI model was developed using label-free optical microscopy to quantify tumor infiltration (AI-infiltration) in surgical margin samples.
- A random forest classifier integrated AI-infiltration with clinical, radiographic, and molecular data.
- The model was trained and validated on a cohort of 80 patients with glioblastoma.
Main Results:
- Higher glioblastoma infiltration was observed in margin samples from recurrent tumors compared to non-recurrent ones (p = 0.026).
- The AI-driven random forest model achieved high prediction accuracy for focal recurrence (86.6% training, 80.3% validation AUC).
- AI-infiltration emerged as the strongest predictor, outperforming molecular features, and maintained performance across tumor locations.
Conclusions:
- AI-based prediction of tumor infiltration can accurately identify sites at high risk for glioblastoma recurrence.
- This approach holds potential for guiding precision, multimodal therapies to specific high-risk areas.
- The findings suggest a novel strategy for managing recurrent brain tumors by predicting recurrence patterns.

